Total Liabilities Equity - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Total Liabilities & Equity Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Total Liabilities & Equity
â‚Ş786.6m
CAGR 3-Years
34%
CAGR 5-Years
85%
CAGR 10-Years
62%
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Total Liabilities & Equity
$41.3B
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Redhill Biopharma Ltd
NASDAQ:RDHL
Total Liabilities & Equity
$22m
CAGR 3-Years
-52%
CAGR 5-Years
-15%
CAGR 10-Years
-6%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Total Liabilities & Equity
$42m
CAGR 3-Years
-3%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Total Liabilities & Equity
$57.3m
CAGR 3-Years
30%
CAGR 5-Years
3%
CAGR 10-Years
-3%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Total Liabilities & Equity
â‚Ş482.9m
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
4%

See Also

What is InterCure Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
786.6m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Total Liabilities & Equity amounts to 786.6m ILS.

What is InterCure Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
62%

Over the last year, the Total Liabilities & Equity growth was -18%. The average annual Total Liabilities & Equity growth rates for InterCure Ltd have been 34% over the past three years , 85% over the past five years , and 62% over the past ten years .

Back to Top